For Mary Kay, It’s Mission Critical: We’ve Accelerated Our Digital Innovation Efforts to Unleash the Full Potential of Women Entrepreneurs
Below is a statement by Deborah Gibbins, Chief Operating Officer, Mary Kay Inc., in celebration of International Women’s Day 2023.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230308005697/en/
Deborah Gibbins, Mary Kay’s Chief Operating Officer (Photo courtesy: Mary Kay Inc.)
37% of women worldwide do not have access to the internet. I know - I had to read that twice, too.1
37%! The number is staggering. It feels impossible. In our always-on, always-connected world, how can more than a third of all women in the world remain “unconnected”? This shocking reality - and its implications - fuel this year’s International Women’s Day theme: “DigitALL: Innovation and technology for gender equality.”
As Chief Operating Officer at Mary Kay, I know the role technology plays in all aspects of business – especially entrepreneurial business. To maximize the opportunity offered by technology, digital literacy skills are an absolute requirement for women entrepreneurs to fully participate in our global economy. They are also a necessity for civic and social engagement.
The foundations for the Fourth Industrial Revolution are digital and they are being laid right now. For all of us this revolution holds the tremendous opportunity to leverage technology and innovation to advance women entrepreneurship and equality. The time is now to ensure women reap the benefits of this digital transformation.
The digital economy won’t wait for anyone to catch up. Women’s exclusion from the digital world has shaved $1 trillion from the gross domestic product of low- and middle-income countries in the last decade.2 Once again, change is not happening fast enough for women.
We can fix this. We must fix this.
To reach their full potential, women business owners around the world must not only have access to the digital tools we take for granted, but they must have the right skills and training to use them effectively.
That’s why bridging the digital gender gap is so personal to us at Mary Kay, a company founded by a woman for women.
Our founder, Mary Kay Ash, had a vision to offer women unmatched entrepreneurial opportunities for advancement and personal success. That means something different today than it did in the ‘60s, but that same spirit remains. As an entrepreneurship development company, our focus is lifting women entrepreneurs up and addressing the barriers they face in establishing or growing their business. Digitalization is one of them.
At Mary Kay, we are determined to put women entrepreneurs at the center of the digital transformation.
We’ve accelerated our digital innovation efforts – this includes revolutionizing Mary Kay’s Independent Beauty Consultants’ (IBCs) ability to unleash their full potential through digital upskilling, the development and roll-out of innovative digital tools, from award-winning apps featuring augmented reality (AR), to connecting IBCs with their customers in more effective and seamless ways. We’re improving not only the experience for the independent sales force, but for their customers around the world.
Here are some of the latest examples of our commitment to empower Mary Kay’s independent sales force to harness the power of digital:
- In Europe, our award-winning “Link & Learn” is an integrated education platform comprising a robust learning curriculum IBCs can access anytime, anywhere. This self-paced, interactive learning system helps consultants put their dreams into action by providing a competency-based curriculum with relevant, expert-driven content while connecting them with a community of like-minded consultants. It includes content focused on the key areas of competency that are essential for success at each step of the career path. With this content, consultants strategically focus on key topics and acquire skills such as Selling Skills, Business Skills, Product Knowledge and Understanding the Mary Kay Way. Mary Kay has received numerous awards for this educational platform, including a coveted gold ranking in the Education category in the “2019 Spring Omni Awards.” In 2021 Mary Kay Poland received the “Innovative Company” award for the program from the Home & Market magazine, and in 2018 it was awarded a “Technology Excellence Award” from the Brandon Hall Group.
- The InTouch® platform is a one-stop shop mobile platform which provides millions of IBCs around the world 24-hour access to information, and services to effectively manage their Mary Kay business. It includes many features to enhance their knowledge of the beauty industry through product education, basic business skills through marketing and sales tools, and a professional network. With this app, IBCs can access product ingredient information and material to share with their customers or as a quick reference.
- The Salesforce.com platform has also recently been rolled out to our Mary Kay markets via the Mary Kay InTouch site, enabling a more seamless use of digital technology in day-to-day operations, including placing orders. IBCs receive 24/7 support from their local Mary Kay teams and save time to focus on tasks that add more value to their business.
- Mary Kay Mirror Me™ is our real-time makeover app using augmented reality to apply makeup trends and color products for real life application. After finding their perfect look, customers can add products to their shopping bag and connect with an IBC. Mirror Me™ is available in the North America, Europe and Latin America regions.
- Mary Kay® Skin Analyzer is a tool that brings skin care and technology together at one’s fingertips. It helps customers understand the unique characteristics of their skin and create a customized skin care routine and is available in the North America, Asia-Pacific and Latin America regions.
- And finally, the newly launched Mary Kay Interactive Catalog brings Mary Kay catalogs to life with easy product ordering, GIFs, videos, shareable wish lists, instant augmented reality makeovers and more. The catalog is available in the North America, Europe and Latin America regions.
We also believe in digital collaborations to help women entrepreneurs harness the power of digital throughout the world. To this end, we have joined forces with:
- The International Telecommunication Union (ITU). In collaboration with the Women Entrepreneurship Accelerator (WEA) and Mary Kay Global, ITU has launched the WEA Digital Innovation Challenge to build enabling eco-systems for women entrepreneurs. This challenge supports the commitment of WEA to empower 5 million women entrepreneurs by 2030. WEA is a multi-partnership initiative on women's entrepreneurship convening 6 United Nations agencies comprising International Telecommunication Union (ITU), International Labour Organization (ILO), International Trade Centre (ITC), the United Nations Development Programme (UNDP), UN Global Compact (UNGC) and UN Women. The Challenge’s pitch finale will be held on March 13th during the Commission on the Status of Women (CSW67). An expert jury will select 10 digital best practices and solutions to create a more gender-inclusive eco-system for start-ups and scale-ups to address the obstacles women entrepreneurs face in developing technologies. The winners will gain access to the Digital Innovation Eco-System Program from ITU where they will receive capacity-building and specialized mentorship. Register to the event here.
- In support of WEA, ITU is also working to address the gender digital skills gap by providing women entrepreneurs access to free, high-quality learning modules required to advance in the digital economy. To be rolled out over the course of 2023, the initiative will be translated into several languages. Supported by Mary Kay, the project includes 17 online modules including general digital skills training for aspiring and experienced women entrepreneurs; digital skills for women entrepreneurs in the textiles and apparel sector, and management skills for women entrepreneurs in technology. These learning modules provide broad professional training for any woman entrepreneur regardless of her location or business focus.
- As a product of WEA, the International Trade Centre (ITC) launched its first-ever free online Entrepreneurship Certificate Programme in 2022 under its SheTrades program. Powered by Mary Kay, the 27-module digital curriculum, enriched with 200 videos, covers the 7 key stages of the entrepreneurial journey and is available in English, Spanish, French, and soon Arabic and Chinese.
- Mary Kay is also a proud commitment maker to the Generation Equality Action Coalition on Technology and Innovation as we believe in the power of multi-stakeholder partnerships to spark a more equal and diverse digital transformation.
And we’re just getting started. The digital revolution is underway. Let’s not miss out on this golden opportunity to enable women and girls to champion entrepreneurship in the digital age!
About Mary Kay
One of the original glass ceiling breakers, Mary Kay Ash founded her dream beauty company in 1963 with one goal: enriching women’s lives. That dream has blossomed into a multibillion-dollar company with millions of independent sales force members in more than 35 countries. As an entrepreneurship development company, Mary Kay is committed to empowering women on their journey through education, mentorship, advocacy, networking, and innovation. Mary Kay is dedicated to investing in the science behind beauty and manufacturing cutting-edge skincare, color cosmetics, nutritional supplements, and fragrances. Mary Kay believes in enriching lives today for a sustainable tomorrow, partnering with organizations from around the world focusing on promoting business excellence, supporting cancer research, advancing gender equality, protecting survivors from domestic abuse, beautifying our communities, and encouraging children to follow their dreams. Learn more at marykayglobal.com, find us on Facebook, Instagram, and LinkedIn or follow us on Twitter.
1 ITU (2022). Facts and Figures 2022 - The gender digital divide (itu.int)
2 UN Women. Progress on the Sustainable Development Goals. The Gender Snapshot 2022.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230308005697/en/
Contact information
Mary Kay Inc.
media@mkcorp.com
+1-972-687-5332
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Hemato-Oncology Trials: AOP Health Presents New Results at Top Congress ASH7.12.2025 18:00:00 EET | Press release
AOP Health continues to advance its clinical research program in myeloproliferative neoplasms, a special group of rare blood cancers. The company, specialized in rare diseases, presented the results of two scientific investigations at the 67th American Society of Hematology Association (ASH) Annual Meeting 2025 held in Orlando, FL, USA. The results provide new insights in treatment strategies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251207587915/en/ Dr. Martin Steinhart, CEO AOP Health; Photo credit: AOP Health/Studio Koekart ROP-ET and BESREMI PASS One of the clinical studies, ROP-ET, examined the use of ropeginterferon alfa-2b in people with essential thrombocythemia (ET), a disease in which the body produces too many platelets. The trial, a prospective, multicenter, single-arm phase III study, investigated the safety and efficacy of ropeginterferon alfa-2b in ET patients unable to receive available cytoreductive th
CoMotion GLOBAL 2025 Launches in Riyadh: Global Mobility Leaders Unite in Saudi Capital to Chart Urban Future7.12.2025 14:00:00 EET | Press release
Riyadh is rapidly becoming one of the world's most ambitious urban mobility laboratories, where next-generation technologies move from blueprint to real-world deployment on city streets at unprecedented scale. CoMotion GLOBAL 2025, the world's most influential gathering of urban mobility leaders, opens today in Riyadh for a three-day summit bringing together innovators from Africa, Asia, Europe, the Americas, and the Middle East. Running December 7-9, the event will explore how electrification, autonomy, AI-enabled transport, and giga-project urbanism are reshaping cities worldwide. The summit will spotlight everything from high-performance EVs and breakthrough autonomous fleets to emerging-market transport solutions and new mobility models, demonstrating how the Kingdom is opening new pathways for global mobility leadership. Strategic Partnerships Powering the Summit CoMotion GLOBAL 2025 is hosted by the Saudi Conventions & Exhibitions General Authority (SCEGA), supported by key Saudi
Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67 th American Society of Hematology (ASH) Annual Meeting6.12.2025 16:30:00 EET | Press release
Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which Ono obtained exclusive global rights for the development and commercialization of sapablursen. “In the treatment of PV, phlebotomy and cytoreductive therapy are performed as treatments for preventing thrombosis. Phlebotomy is the most common treatment for PV, in which blood
Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera6.12.2025 16:30:00 EET | Press release
Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) announce that new 52-week results from the pivotal Phase 3 VERIFY study evaluating rusfertide in patients with polycythemia vera (PV) will be presented in an oral presentation at the 67th American Society of Hematology (ASH) Annual Meeting and Exposition. These findings further reinforce rusfertide’s efficacy and safety and demonstrate durability of response, with 61.9% of patients continuously treated with rusfertide maintaining absence of phlebotomy eligibility from baseline to Week 52. “The 52-week data demonstrated the sustained efficacy of rusfertide, reducing the need for patients to receive phlebotomy while maintaining hematocrit control,” said Dr. Andrew T. Kuykendall, M.D., VERIFY Lead Investigator and Associate Member in the Department of Hematology at Moffitt Cancer Center. “The 32-week VERIFY primary results were already promising, and this deeper understanding of the durability of r
Vertex Presents New Data on CASGEVY ® , Including First-Ever Data in Children Ages 5-11 Years, at the American Society of Hematology Annual Meeting and Announces Plan for Global Regulatory Submissions6.12.2025 14:01:00 EET | Press release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data from multiple studies demonstrating the clinical benefits of CASGEVY® (exagamglogene autotemcel) in people ages 5 years and older living with severe sickle cell disease (SCD) or transfusion-dependent beta thalassemia (TDT). The results, including the first presentation of clinical data from pivotal studies in children ages 5-11 years, and longer-term data from the pivotal studies of people with severe SCD and TDT ages 12 years and older, will be presented at the American Society of Hematology (ASH) Annual Meeting. CASGEVY is currently approved for eligible people ages 12 years and older with SCD or TDT in the United States, Great Britain, the European Union, the Kingdom of Saudi Arabia, the Kingdom of Bahrain, Kuwait, Qatar, Canada, Switzerland and the United Arab Emirates. “These results — the first clinical data ever presented on any genetic therapy for children ages 5-11 years with SCD — again demonstrate the tr
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
